LOUIF yields 20000.00% · JNJ yields 2.13%● Live data
📍 LOUIF pulled ahead of the other in Year 1
Combined, LOUIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LOUIF + JNJ for your $10,000?
South Shore Holdings Limited, an investment holding company, engages in the hospitality, entertainment, and construction businesses in Hong Kong, Macau, Singapore, and Malaysia. It operates through Management Contracting, Property Development Management, Property Investment, and Hotel Operation segments. The Management Contracting segment offers building construction and civil engineering services. The Property Development Management segment develops and manages projects, as well as provides facilities and asset management services. The Property Investment segment invests in properties. The Hotel Operation segment operates hotels with ancillary facilities. The company also offers electrical, mechanical, and building services, as well as finance, interior decoration and foundation works, and management and secretarial services. In addition, it is involved in the trade and letting of plant and machinery; and trade and installation of building materials. The company was formerly known as The 13 Holdings Limited and changed its name to South Shore Holdings Limited in June 2018. South Shore Holdings Limited was founded in 1946 and is based in Quarry Bay, Hong Kong.
Full LOUIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.